|
|
|
Volumn 14, Issue 6, 2001, Pages 447-452
|
|
Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: Design of a prospective randomized multicenter trial
a
|
|
Author keywords
ACE inhibitors; Chronic renal failure; Hypertension; IgA nephropathy; Progression; Proteinuria; Randomized trials
|
|
Indexed keywords
ATENOLOL;
BENAZEPRIL;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOGLOBULIN A;
NIFEDIPINE;
PLACEBO;
PROTEIN;
ADOLESCENT;
ADULT;
ARTICLE;
CHILD;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DISEASE COURSE;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
EUROPE;
FEMALE;
FOLLOW UP;
GENETIC ANALYSIS;
HISTOLOGY;
HUMAN;
IMMUNOGLOBULIN A NEPHROPATHY;
IMMUNOLOGICAL PARAMETERS;
IN VITRO STUDY;
KIDNEY FAILURE;
KIDNEY FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
MULTICENTER STUDY;
PROSPECTIVE STUDY;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
RENOVASCULAR HYPERTENSION;
ADOLESCENT;
ADULT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZAZEPINES;
CHILD;
CHILD, PRESCHOOL;
DOUBLE-BLIND METHOD;
FEMALE;
GLOMERULONEPHRITIS, IGA;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
PROTEINURIA;
RESEARCH DESIGN;
|
|
EID: 0035717259
PISSN: 11218428
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (23)
|
